|
Scientist, Oligonucleotide Drug Substance
|
Cambridge, MA, US, 02142
|
Jun 9, 2026
|
Full-Time
|
|
|
Senior Manager, External Reporting
|
Cambridge, MA, US, 02142
|
Jun 10, 2026
|
Full-Time
|
|
|
Associate Scientist II, Oncology
|
Cambridge, MA, US, 02142
|
Jun 10, 2026
|
Full-Time
|
|
|
Vice President, Target Discovery, Validation, and Human Genetics
|
Cambridge, MA, US, 02142
|
Jun 10, 2026
|
Full-Time
|
|
|
Senior Director, Biocatalysis
|
Cambridge, MA, US, 02142
|
Jun 10, 2026
|
Full-Time
|
|
|
Associate Scientist II, Oligonucleotide Synthesis
|
Cambridge, MA, US, 02142
|
Jun 10, 2026
|
Full-Time
|
|
|
Associate Director, Medical Training
|
Zug, CH, 6300
|
Jun 10, 2026
|
Full-Time
|
|
|
Senior Associate Scientist, Oncology
|
Cambridge, MA, US, 02142
|
Jun 11, 2026
|
Full-Time
|
|
|
Associate Director, Quality Technology Delivery
|
Cambridge, MA, US, 02142
|
Jun 11, 2026
|
Full-Time
|
|
|
Business Account Executive, TTR - New York, NY
|
Cambridge, MA, US, 02142
|
Jun 11, 2026
|
Full-Time
|
|
|
Business Account Executive, TTR - Providence, RI
|
Cambridge, MA, US, 02142
|
Jun 11, 2026
|
Full-Time
|
|
|
Business Account Executive, TTR - West Texas
|
Cambridge, MA, US, 02142
|
Jun 11, 2026
|
Full-Time
|
|
|
Business Account Executive, TTR - Cincinnati, OH
|
Cambridge, MA, US, 02142
|
Jun 11, 2026
|
Full-Time
|
|
|
Business Account Executive, TTR - Rockford, IL
|
Cambridge, MA, US, 02142
|
Jun 11, 2026
|
Full-Time
|
|
|
Business Account Executive, TTR - San Diego, CA
|
Cambridge, MA, US, 02142
|
Jun 11, 2026
|
Full-Time
|
|
|
Business Account Executive, TTR - Tampa, FL
|
Cambridge, MA, US, 02142
|
Jun 11, 2026
|
Full-Time
|
|
|
Business Account Executive, TTR - Long Island, NY
|
Cambridge, MA, US, 02142
|
Jun 11, 2026
|
Full-Time
|
|
|
Business Account Executive, TTR - Jacksonville, FL
|
Cambridge, MA, US, 02142
|
Jun 11, 2026
|
Full-Time
|
|
|
Business Account Executive, TTR - Virginia
|
Cambridge, MA, US, 02142
|
Jun 11, 2026
|
Full-Time
|
|
|
Business Account Executive, TTR - Alabama
|
Cambridge, MA, US, 02142
|
Jun 11, 2026
|
Full-Time
|
|